These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21083020)

  • 21. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.
    de Jong D
    J Clin Oncol; 2005 Sep; 23(26):6358-63. PubMed ID: 16155020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International and Italian prognostic indices in follicular lymphoma.
    Perea G; Altés A; Montoto S; López-Guillermo A; Bosch F; Jiménez M; Esteve J; Domingo E; Ribera JM; Pedro C; Martino R; Briones J; Sureda A; Brunet S; Sierra J; Montserrat E
    Haematologica; 2003 Jun; 88(6):700-4. PubMed ID: 12801847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.
    Sacchi S; Pozzi S; Marcheselli R; Federico M; Tucci A; Merli F; Orsucci L; Liberati M; Vallisa D; Brugiatelli M;
    Cancer; 2007 Jul; 110(1):121-8. PubMed ID: 17503433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic systems for lymphomas.
    Johnston A; Salles G
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):839-61, viii. PubMed ID: 18954740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
    Carreras J; Lopez-Guillermo A; Roncador G; Villamor N; Colomo L; Martinez A; Hamoudi R; Howat WJ; Montserrat E; Campo E
    J Clin Oncol; 2009 Mar; 27(9):1470-6. PubMed ID: 19224853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current treatment for malignant lymphomas].
    Usui N
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2191-9. PubMed ID: 18079619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment strategies in follicular lymphomas: current status and future perspectives.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Forstpointner R; Nickenig C; Unterhalt M
    J Clin Oncol; 2005 Sep; 23(26):6394-9. PubMed ID: 16155025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
    J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma.
    Strauss SJ; Morschhauser F; Rech J; Repp R; Solal-Celigny P; Zinzani PL; Engert A; Coiffier B; Hoelzer DF; Wegener WA; Teoh NK; Goldenberg DM; Lister TA
    J Clin Oncol; 2006 Aug; 24(24):3880-6. PubMed ID: 16864854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.
    Wahlin BE; Sander B; Christensson B; Kimby E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):388-97. PubMed ID: 17255259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma.
    Troch M; Wöhrer S; Raderer M
    Anticancer Res; 2010 Feb; 30(2):635-9. PubMed ID: 20332482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
    Gulmann C; Espina V; Petricoin E; Longo DL; Santi M; Knutsen T; Raffeld M; Jaffe ES; Liotta LA; Feldman AL
    Clin Cancer Res; 2005 Aug; 11(16):5847-55. PubMed ID: 16115925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refining the treatment of follicular lymphoma.
    Buske C; Gisselbrecht C; Gribben J; Letai T; McLaughlin P; Wilson W
    Leuk Lymphoma; 2008; 49 Suppl 1():18-26. PubMed ID: 18821429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting follicular lymphoma: high versus low risk.
    Smith SM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():561-7. PubMed ID: 24319232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful?
    Solal-Céligny P; Cahu X; Cartron G
    Int J Hematol; 2010 Sep; 92(2):246-54. PubMed ID: 20803352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.
    Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
    Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.
    Federico M; Guglielmi C; Luminari S; Mammi C; Marcheselli L; Gianelli U; Maiorana A; Merli F; Bellei M; Pozzi S; Stelitano C; Lazzaro A; Gobbi PG; Baldini L; Bergantini S; Fregoni V; Brugiatelli M
    Haematologica; 2007 Nov; 92(11):1482-8. PubMed ID: 18024396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma.
    Martinka M; Comeau T; Foyle A; Anderson D; Greer W
    Clin Invest Med; 1997 Dec; 20(6):364-70. PubMed ID: 9413633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.